Montpellier, France

Rachel Bras-Gonçalves

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Institut De Recherche Pour Le Developpement (Ird). Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachel Bras-Gonçalves. Retrieved from https://idiyas.com/inventor/rachel-bras-goncalves

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rachel Bras-Gonçalves: Innovator in Antigenic Protein Research

Introduction

Rachel Bras-Gonçalves is a notable inventor based in Montpellier, France. She has made significant contributions to the field of biotechnology, particularly in the development of expression vectors for antigenic proteins. Her work is essential for advancing therapeutic and vaccine-oriented applications.

Latest Patents

Rachel holds 1 patent related to an expression vector of a gene coding for an antigenic protein of promastigote. This invention is characterized by its inclusion of a PSA gene insert in the opposite orientation. The implications of her work extend to the development of mutants that under-express or no longer express genes coding for antigenic proteins, which can be pivotal in therapeutic and vaccine development.

Career Highlights

Throughout her career, Rachel has been associated with esteemed institutions such as the Institut de Recherche pour le Développement (IRD). Her research has focused on innovative solutions that address critical health challenges.

Collaborations

Rachel has collaborated with notable professionals in her field, including Jean-Loup Lemesre and Philippe Holzmuller. These partnerships have enhanced her research and contributed to the advancement of her projects.

Conclusion

Rachel Bras-Gonçalves is a pioneering inventor whose work in antigenic protein research is making a significant impact in biotechnology. Her contributions are vital for the future of therapeutic and vaccine development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…